Total of 4933 patients were enrolled. Of 1239 individuals who met study criteria, 585 and 684 received remimazolam and propofol, respectively. Propensity score matching resulted in 333 matched pairs for further analysis.
/
本観察研究において有害事象は発生しなかった。
No adverse events occurred for this retrospective observational study.
Patients who received remimazolam anesthesia had a significantly higher incidence of postoperative nausea and vomiting compared with patients who received propofol anesthesia both before and after propensity score matching. (27% vs 22% p<0.001 and 35% vs. 21% p<0.001)
A retrospective, observational, single-center cohort study comparing the occurrence of postoperative nausea and vomiting with remimazolam and propofol anesthesia was conducted.
Bias in anesthetic selection was adjusted for using propensity score matching techniques.
A total of 1239 subjects were included and 333 pairs were created. Remimazolam anesthesia was associated with a higher incidence of postoperative nausea and vomiting than propofol anesthesia and was robust after propensity score adjustment.
2022年08月26日
3 IPDシェアリング
無
No
管理的事項
研究の種別
観察研究
登録日
令和4年9月2日
jRCT番号
jRCT1041210079
1 臨床研究の実施体制に関する事項及び臨床研究を行う施設の構造設備に関する事項
(1)研究の名称
全身麻酔薬レミマゾラムの術後悪心嘔吐の発生に関する単施設後ろ向き観察研究
Comparison of the effects of remimazolam, propofol, and inhalational agent on postoperative nausea and vomiting: a propensity score matching study.
レミマゾラム麻酔後に発生する術後悪心嘔吐に関する観察研究
Postoperative nausea and vomiting after general anesthesia with Remimazolam.
(2)研究責任医師(多施設共同研究の場合は、研究代表医師)に関する事項等
鈴木 祐二
Suzuki Yuji
60793304
/
浜松医科大学附属病院
Department of Anesthesiology and Intensive Care Medicine, Hamamatsu University School of Medicine
麻酔科蘇生科
431-3192
/
静岡県浜松市東区半田山 1-20-1
1-20-1, Handayama, Hamamatsu, Shizuoka, Japan
0534352738
suzukiy@hama-med.ac.jp
鈴木 祐二
Suzuki Yuji
浜松医科大学医学部附属病院
Department of Anesthesiology and Intensive Care Medicine, Hamamatsu University School of Medicine
less than 20 years of age, incorrect enrollment other than general anesthesia, postoperative artificial respiration, cancellation of surgery after induction of anesthesia, lack of consciousness after anesthesia, reoperation within 24 hours after anesthesia, insufficient data due to follow-up shorter than 24 hours, and maintenance with a combination of propofol and remimazolam.